Proton Therapy Market 2023 – Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Market Size & Forecast 2030

Page: 215 | Report Code: LS221206 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content.

Proton Therapy Insights:

Proton therapy is a sort of radiotherapy used to treat cancer. It uses protons, which are charged particles, to focus on tumors with high precision and minimal damage to surrounding healthy tissue. The proton beam is delivered to the tumor site employing a particle accelerator, and the energy from the beam destroys the cancer cells. It's an increasingly popular sort of cancer treatment thanks to its ability to deliver high doses of radiation to tumors while minimizing exposure to healthy tissue. It's particularly effective in treating tumors in sensitive areas, like the brain, spine, and prostate.

Proton Therapy Market

The proton therapy market is a growing segment within the radiotherapy market, driven by advancements in technology and the increasing prevalence of cancer. The worldwide proton therapy market size was valued at $1.7 billion in 2022 and is projected to succeed at $3.9 billion by 2030, with a CAGR of 10.8% during the forecast period (2023-2030). The single-room systems segment accounted for the most important share of the market in 2022, due to their cost-effectiveness and simple installation.

The prostatic adenocarcinoma segment accounted for the most important share of the market in 2020, thanks to the high prevalence of prostate cancer and the effectiveness of proton therapy in treating this sort of cancer. Hospitals are the first user of the therapy owing the most important market share among end-user industries. North America is the largest marketplace for proton therapy, followed by Europe and Asia-Pacific. The high prevalence of cancer, favorable reimbursement policies, and the presence of established healthcare infrastructure are a number of the key factors driving market growth in these regions.

Proton Therapy Market Growth Drivers:

The growing incidence of cancer worldwide is a major driver of the proton therapy market because it is especially effective in treating certain sorts of cancer, like prostate, lung, and brain cancer. Advances in proton therapy technology have improved treatment precision and reduced the danger of side effects. This has made proton therapy a more viable treatment option for a wider range of cancer patients.

As more people become conscious of the advantages of proton therapy, demand for the treatment is probably going to extend. Additionally, more healthcare providers are offering proton therapy services, which are making the treatment more accessible to patients.

Governments and insurance providers are increasingly recognizing the advantages of proton therapy and are providing reimbursement for the treatment which helps to form proton therapy cheaper for patients. The proton therapy market is additionally attracting increasing investments from both private and public sources resulting in the event of the latest and more advanced proton therapy systems.

Proton Therapy Market Segmentation:

1.       By System: Single-Room System, Multi-Room Systems

2.       By Therapy: Single-Field Proton Therapy, Multi-Field Proton Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Therapy (IMPT), Spot Scanning Proton Therapy

3.       By Product: Equipment, Services

4.       By Indication: Prostate Cancer, Brain& CNSCancer, Head & Neck Cancer, Lung Cancer, Pediatric Cancer, Gastrointestinal Cancer, Breast Cancer, Others

5.       By End User: Hospitals, Proton Therapy Centers, Research Institutions

6.       By Region: North America, Europe, Asia Pacific, Rest of the World (RoW)

Proton Therapy Market System Segment Review

Single-room proton therapy systems are designed to deliver proton therapy from one clinic. These systems are typically smaller and less expensive than multi-room systems, making them a well-liked choice for smaller hospitals and clinics. The single-room system holds the most important market share of around 60.0% and is predicted to grow significantly at a CAGR of 8.0% (2023-2030), particularly in developing countries. Mevion Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, ProTom International, Inc., and Sumitomo Heavy Industries, Ltd. are some key players offering single-room proton therapy systems.

Multi-room proton therapy systems are designed to deliver proton therapy from multiple treatment rooms. These systems are typically larger and costlier than single-room systems, but they provide greater flexibility and throughput. Some of the major companies providing these types of systems include Varian Medical Systems, Inc., ProNova Solutions, LLC, Ion Beam Applications (IBA) SA, Optivus Proton Therapy, Inc., and Advanced Oncotherapy PLC.

Proton Therapy Market Therapy Segment Review

Single-field proton therapy delivers protons from a single direction to target the cancerous cells. It is the most common type of proton therapy used with the largest market share and is effective in treating many types of cancer. This is expected to grow at a CAGR of 6.5% during (2023-2030) with Hitachi, Ltd. being the leading manufacturer of single-field proton therapy systems, with several other profound players including IBA Worldwide, Mevion Medical Systems, Inc., ProTom International, Inc., and Sumitomo Heavy Industries, Ltd.

Multi-field proton therapy delivers protons from multiple directions to target cancerous cells allowing for more precise targeting of the tumor and is particularly effective in treating tumors that are irregularly shaped or difficult to reach. Pencil beam scanning is a newer type of proton therapy that uses a narrow beam of protons that is scanned across the tumor to deliver the radiation dose which allows for more precise targeting of the tumor while minimizing damage to healthy tissue. The market is expected to grow at the highest rate, with a projected CAGR of around 12.0% during the aforementioned period. Varian Medical Systems, Inc. is a leading provider of multi-field and pencil beam scanning proton therapy systems, with several other profound players including Mevion Medical Systems, Inc., Hitachi, Ltd., Ion Beam Applications (IBA) SA, ProNova Solutions, LLC, Advanced Oncotherapy PLC, and Sumitomo Heavy Industries, Ltd.

Intensity-modulated proton therapy (IMPT) uses multiple beams of protons that are modulated to deliver different radiation doses to different parts of the tumor allowing for a more customized treatment that can be adjusted as needed during the course of treatment. Spot scanning proton therapy is a type of proton therapy that uses a series of small "spots" of protons to deliver the radiation dose to the tumor. Both IMPT and Spot scanning are expected to grow at a CAGR of 8.0% and 7.5% respectively from 2023 to 2030.

Proton Therapy Market Product Segment Review

The equipment segment includes the varied components required for proton therapy, such as cyclotrons, synchrotrons, beam transport systems, treatment planning software, and others. The services segment includes installation, maintenance, and upgrading of proton therapy equipment. It also includes the training of staff and consulting services. As proton therapy is a highly specialized treatment, the services segment is predicted to grow alongside the equipment segment. As of 2022, the equipment segment holds the largest and most important share of the market, with a worldwide market share of around 70%. These two categories are expected to grow at a CAGR of 9.0% and 10.0% respectively from 2023 to 2030. 

Proton Therapy Market Regional Synopsis:

The Proton Therapy market in North America is predicted to dominate the market in terms of revenue and is predicted to grow at a CAGR of 7.2% during the forecast period (2023-2030). The market is predicted to be worth $2.3 billion by 2030 against an earlier estimation of $1.3 billion in 2022 driven by the high adoption rate of advanced cancer therapies and high healthcare expenditure. Some of the key players in the North American proton therapy market include Varian Medical Systems, Hitachi, and Mevion Medical Systems.

Europe is predicted to carry the second-largest share of the proton therapy market due to factors like the rising incidence of cancer, increasing investments in cancer research, and growing awareness regarding the advantages of proton therapy. The market is predicted to grow at a CAGR of 7.5% during the forecast period (2023-2030) with increasing adoption of the technology in countries such as Germany, France, and the UK. IBA, Siemens Healthineers, and ProNova Solutions are some of the key players in the region.

The Asia Pacific region is predicted to witness the very best rate of growth during the forecast period, due to the increasing prevalence of cancer, growing healthcare infrastructure, and rising income in countries like India, Japan, and China. The market is predicted to grow at a CAGR of 10.3% with Hitachi, IBA, and Sumitomo Heavy Industries being the key players in the region especially in countries like China, Japan, India, and South Korea.

The Rest of the World (RoW) region includes countries like Brazil, South Africa, and the Middle East, and the overall market is predicted to grow at a CAGR of 7.0% from 2023 to 2030due to factors like rising healthcare expenditure, increasing prevalence of cancer, and growing awareness regarding the advantages of proton therapy. The region has a significant presence of key global players such as Varian Medical Systems, IBA, and Mevion Medical Systems.

Proton Therapy Market Key Challenges:

Proton therapy is a costly treatment option, which limits its accessibility to patients. The value of building and operating a proton therapy center is additionally high, which makes it difficult for hospitals and clinics to take a position in this technology market. Although proton therapy has been used for several decades, there's still a scarcity of strong clinical evidence to support its use making it difficult for insurance companies to cover the prices of proton therapy, as they require evidence of its efficacy and safety.

Proton therapy isn't widely available, as there are relatively few proton therapies centers worldwide that limit access to the present treatment option for patients who may benefit from it. There are several other treatment options available for cancer, including surgery, chemotherapy, and radiotherapy which are well-established and have a proven diary of success, making it difficult for proton therapy to compete.

Proton therapy requires highly specialized technology, including particle accelerators and sophisticated treatment planning software. These technologies are expensive and need highly skilled personnel to work, which may be a challenge for a few hospitals and clinics.

Proton Therapy Market Key Global Players:

The competitive landscape of the Proton Therapy market is shaped by several factors, including:

·         The Proton Therapy market is subject to varied regulations and standards associated with radiotherapy and corporations which will suit regulatory requirements and meet industry standards are more likely to realize consumer trust and compete more effectively.

·         Companies that have the power to expand market reach and establish a robust presence in new regions mark an important factor to realize market share and compete more effectively. Offering cheaper systems without sacrificing performance or quality is probably going to assist gain market share.

·         Companies are forming strategic alliances to leverage each other's strengths and expertise to develop more comprehensive and integrated solutions. These partnerships also help companies to expand their market reach and compete more effectively.

Numerous players are vying for market share and investing in new technologies and product development to stay ahead of the curve in the market. Some of the key global players in the Proton Therapy market include:

·         Advanced Oncotherapy PLC

·         Hitachi, Ltd.

·         Ion Beam Applications (IBA) SA

·         Mevion Medical Systems, Inc.

·         Optivus Proton Therapy, Inc.

·         ProNova Solutions, LLC.

·         ProTom International, Inc.

·         Provision Healthcare

·         Sumitomo Heavy Industries, Ltd.

·         Varian Medical Systems, Inc.

These companies are investing in research and development activities to improve their product offerings and gain a competitive advantage in the market. They are also engaged in strategic partnerships, collaborations, and mergers and acquisitions to expand their market share and global presence.

The report on the Proton therapy market covers the following aspects:

·         Market Overview: A general overview of the global Proton therapy market, including its current size and growth projections for the future.

·         Market Segmentation: A breakdown of the market by system, therapy, product, indication, end-user, and geographic region.

·         Market Dynamics: An analysis of the key drivers, challenges, and trends affecting the growth of the Proton therapy market.

·         Competitive Landscape: A comprehensive analysis of the leading players in the Proton therapy market, including their market share, product offerings, and key strategies.

·         Regional Analysis: A detailed analysis of the Proton therapy market by geographic region, including market size, growth projections, and key trends for each region.

·         Company Profiles: In-depth profiles of key players in the Proton therapy market, including their business overview, product offerings, financial performance, and recent developments.

·         Market Forecast: Projections for the future growth of the Proton therapy market, including market size, growth rate, and key trends for the next five to ten years.

 

Attributes

Details

Base Year

2022

Trend Period

2018 – 2032

Forecast Period

2023 – 2030

Pages

215

System Segment

Single-Room System, Multi-Room Systems

Therapy Segment

Single-Field Proton Therapy, Multi-Field Proton Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Therapy (IMPT), Spot Scanning Proton Therapy

Product Segment

Equipment, Services

Indication Segment

Prostate Cancer, Brain Cancer, Head & Neck Cancer, Lung Cancer

End-user Segment

Hospitals, Proton Therapy Centers, Research Institutions

Company Profiles

Hitachi, Ltd., Ion Beam Applications (IBA), Mevion Medical Systems, Optivus Proton Therapy, Inc., ProNova Solutions, LLC., ProTom International, Inc., Provision Healthcare, and Others

Edition

4th edition

Publication

April 2023

 

Buy Report

  • $1990
  • $2990